Market closedRefreshes 15sData NSENot investment advice
Rossari Biotech

Rossari Biotech

NSE: ROSSARIBSE 543213Basic Materialswww.rossari.com
View MapTV Chart
511.50
7.55+1.50%
DAY506
₹511.50
518
52W375
₹511.50
766
Open510.00
Prev Close503.95
Bid511.47100
Ask511.53100
Volume50.5K52%vs 20D avg
Market Cap₹2,835.07 Cr
Promoter Hold.68.2%
Face Value₹2
Fwd P/E15.05
PEG
EV/EBITDA10.08
P/S1.17
ROA6.18%
Beta0.53
Div Payout1.86%
Valuation

Rossari Biotech Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Rossari Biotech Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Rossari Biotech Ltd trades at a P/E of 18.77× and P/B of 2.10×.

Key MetricsLive · as of 15 Jun 2026
the price tag

Valuation

Market Cap
₹2,835.07 Cr
P/E Ratio
good18.77
P/B Ratio
good2.1
EPS
26.91
the engine

Profitability

ROE
avg11.85%
ROCE
good15.8%
Net Margin
avg6.14%
Op Margin
watch8.55%
the trajectory

Growth

EPS YoY
good33.5%
Revenue YoY
good18.2%
Qtr Sales
good17.6%
Qtr Profit
avg4.39%
the balance sheet

Financial Health

Debt / Equity
watch32.7
Book Value
240.76
Div Yield
avg0.1%
Promoter Hold.
good68.2%
Financials

Rossari Biotech Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Rossari Biotech Ltd, switchable between annual and quarterly views, consolidated or standalone.

Rossari Biotech Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹2,835.07 Cr and reported EPS of ₹26.91.

Period202120222023202420252026
Revenue from Operations
709
1,483
1,656
1,831
2,080
2,396
Other Income
9
12
5
7
4
22
Total Income
719
1,495
1,661
1,838
2,084
2,419
Cost of Goods Sold (COGS)
462
1,105
1,171
1,294
1,433
1,669
Gross Profit
247
378
485
537
647
728
+Operating Expenses
124
194
262
287
382
442
EBITDA
123
183
223
250
265
286
+Non-Operating Expenses
26
61
85
80
85
108
Profit Before Tax (PBT)
106
135
143
177
184
201
+Tax Expense
27
39
37
47
49
53
Profit After Tax (PAT)
80
98
107
131
136
149
Earnings Per Share (EPS)
15.45
17.74
19.45
23.66
24.63
26.94
Diluted Shares Outstanding (Nos.)
5
6
6
6
6
6
+Additional Disclosures
1,075
2,467
2,691
2,954
3,333
3,889
Sales Growth %
109.06
11.66
10.55
13.64
15.19
YoY Sales Growth %
109.06
11.66
10.55
13.64
15.19
Material Cost %
61
65
65
67
62
67
Employee Cost %
6
5
6
6
6
6
Other Cost %
12
9
10
10
12
12
OPM %
17
12
13
14
13
12
Tax %
25
29
26
26
26
27
Profit Growth %
22.05
9.79
21.85
4.35
9.41
Gross Margin %
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA Margin %
0.00
0.00
0.00
0.00
0.00
0.00
Interest Coverage Ratio
0.00
0.00
0.00
0.00
0.00
0.00
Additional Fields
100
135
160
189
198
207
all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Rossari Biotech segment analysis: revenue and profit mix.

Disclosed business segments at Rossari Biotech with their share of revenue and profit, switchable between consolidated and standalone reporting.

Rossari Biotech discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Rossari Biotech Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Rossari Biotech Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

Rossari Biotech Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • ROE 12.20% and ROCE 15.80% indicate strong operational efficiency and profitability.

  • Substantial 68.2% promoter holding reflects strong insider confidence and management alignment.

  • Consistent quarterly sales growth of 17.60% to ₹586 crore shows market demand.

  • Low debt-to-equity ratio 0.18 indicates prudent financial management, reducing risk.

  • Attractive P/E ratio of 25.56 is lower than many industry peers.

bear case

What can break it.

  • Significant stock volatility, 52-week range ₹568-₹885, indicates considerable price risk.

  • Very low dividend yield of 0.08% may not appeal to income investors.

  • Declining FII holdings (8.51% to 2.70%) signal decreased foreign investor confidence.

  • Negative TTM revenue growth of -32.30% raises concerns about recent performance.

  • Negative TTM EPS growth of -1.64% indicates recent earnings contraction.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 24. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 33.20. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.

Shareholding

Rossari shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Rossari — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Rossari Biotech Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Rossari Biotech Ltd is highlighted for quick read-across.

Quick Compare

Largest by Market Cap
Pidilite Industries Ltd
₹1.60 Lakh Cr
Best Profit Growth
Valiant Organics Ltd
1423.00 %
Highest Dividend Yield
Chemcon Speciality Chemicals Ltd
6.67 %
Technicals

Rossari Biotech Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Rossari Biotech Ltd — derived from the live tape, not yesterday's close.

Rossari Biotech Ltd last traded at ₹511.5 with an intraday range of ₹506.45–₹517.9 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹511.50
LevelPrice (₹)Distance% Δ
R4540.35+28.85+5.64%
R3528.90+17.40+3.40%
R2523.40+11.90+2.33%
R1517.45+5.95+1.16%
PIVOT511.950.450.09%
CURRENT511.50
S1483.10-28.40-5.55%
S2494.55-16.95-3.31%
S3500.50-11.00-2.15%
S4506.00-5.50-1.08%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 511.73P: 511.95TC: 512.17
R1
R2
R3
R4
indicator
LTP: 511.50
PDH: 512.00
PDL: 490.60
● Market Sentiment

ROSSARI is trading Below CPR, indicating Bearishness

● CPR Width

CPR is Narrower, suggesting likely for trending moves

● Opening Range

Day's range: 506.45 ~ 514

● Price Position

Trading Inside opening range

Delivery & Volume

Rossari Biotech Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Rossari Biotech Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Rossari Biotech Ltd stood at 51.8% of traded volume, against a 20-day average of 43.5%.

Avg Delivery (20D)43.5%+8.4 ppt latest vs avg
Highest Delivery55.6%on 11 Jun
Avg Volume (20D)1.04 L20-day run-rate
Conviction Trend↑ Strengthening+8.4 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Rossari Biotech announcements: results, concalls, ratings, M&A.

Filings Rossari Biotech sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

Rossari Biotech files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 107 documents below.

  1. 02 Jun 2026Disclosure under SEBI Takeover RegulationsView PDF

    Disclosure under SEBI Takeover Regulations

    Sunil Chari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial…

  2. 28 Apr 2026Analysts/Institutional Investor Meet/Con. Call UpdatesView PDF

    Analysts/Institutional Investor Meet/Con. Call Updates

    Audio recording of Earnings Conference Call for Q4 FY26.

  3. 28 Apr 2026CessationView PDF

    Cessation

    Intimation of completion of tenure of Ms. Aparna Sharma (DIN:07132341) as an Independent Director of the Company from the close of business hours of…

  4. 28 Apr 2026Investor PresentationView PDF

    Investor Presentation

    Rossari Biotech Limited has informed the Exchange about Investor Presentation

  5. 28 Apr 2026Press ReleaseView PDF

    Press Release

    Rossari Biotech Limited informed the Exchange regarding Press Release dated April 27, 2026 titled " Rossari Biotech announces Q4 FY 26 results".

Corporate Actions

Rossari Biotech dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Rossari Biotech has declared, sequenced by announce and record date.

Rossari Biotech corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Rossari Biotech Ltd: business, sector, key facts.

What Rossari Biotech Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Rossari Biotech Ltd operates in the Basic Materials, listed as NSE: ROSSARI, BSE: 543213.

ROSSARI
Basic Materials

Rossari Biotech Ltd

NSE · ROSSARI·BSE · 543213·www.rossari.com

Rossari Biotech Limited is a prominent Indian manufacturer and seller of specialty chemicals, serving both domestic and international markets. Their diverse portfolio encompasses a wide range of applications, showcasing their extensive capabilities within the chemical industry. This breadth allows them to cater to various sectors, demonstrating adaptability and a strategic focus on multiple revenue streams. The company's operational structure is built on a foundation of manufacturing and direct sales, giving them direct control over the production process and market access.

A significant portion of Rossari's business is dedicated to the production and distribution of chemicals for the soap and detergent industry. This is a substantial market segment, and Rossari's presence indicates their competitiveness and ability to meet the demands of this sector. Beyond detergents, they supply chemicals for inks, paints, coatings, ceramics, tiles, pulp and paper production, and cement manufacturing, highlighting the versatility of their chemical offerings and their significant contribution to several essential industrial processes.

Rossari further distinguishes itself through its specialized textile chemical offerings. This segment showcases a deep understanding of the textile industry's diverse needs. They provide chemicals tailored for various fabric types including cotton, polyester, acrylic, wool, silk, and nylon, demonstrating expertise in diverse textile processing techniques. Their commitment extends to functional finishes, denim processing, printing, and environmentally sustainable solutions, reflecting a focus on innovation and meeting contemporary industry demands.

In addition to its industrial chemical production, Rossari has expanded into consumer goods with its line of pet grooming products. These products, marketed under the brands Lozalo, Hunger Fills, and Sniffy, include shampoos, powders, deodorants, sprays, creams, and floor washing liquids. This diversification demonstrates a strategy to broaden their market reach and tap into consumer demand for pet care products. The company also produces poultry nutrition products, including vitamin-mineral formulations, enzyme blends, and herbal supplements, indicating expansion into the agricultural sector and the growing market for animal nutrition.

Founded in 1997 and headquartered in Mumbai, Rossari Biotech has evolved significantly since its inception as Rossari Labtech. The company's continuous growth and diversification illustrate a commitment to innovation, market expansion, and a strong understanding of various industry needs. Their success hinges on their ability to adapt to market trends and deliver high-quality chemical solutions for various sectors, ranging from industrial manufacturing to consumer products.

company facts
Founded / IPO
Employees
SectorBasic Materials
HeadquartersMumbai, India
Market Cap₹2,835.07 Cr
Listed OnNSE
leadership16 on record
Dr. Mikhail Menezes
Director of AHN & Textile Business
Mr. Aseem Dhru
Non-Executive Independent Director
Mr. Edward Menezes
Executive Chairman of the Board, Co-Founder
Mr. Edward Walter Menezes
Co-Founder & Executive Chairman
Mr. Gurudas Aras
Non-Executive Independent Director
Mr. Ketan Sablok
Group Chief Financial Officer
Mr. Ketan Sablok
Group Chief Financial Officer
Mr. Prasad Gadkari
Head of Manufacturing
Mr. Puneet Arora
Head of Mergers & Acquisitions and Global Textile Exports
Mr. Sandeep Tulshyan
Head of Strategic Supply Chain & Procurement
Mr. Sunil Chari
Managing Director, Co-Founder, Executive Director
Mr. Sunil Srinivasan Chari
Co-Founder, MD & Director
§ ∞ · Plainly Answered

Questions investors ask about Rossari Biotech Ltd (ROSSARI).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Rossari Biotech Ltd (ROSSARI)?

The current share price of Rossari Biotech Ltd (ROSSARI) is ₹511.5. Today, the stock has gained by ₹7.55 (1.50%), trading in a range of ₹506.45 to ₹517.9. The stock opened at ₹510 with a trading volume of 50,507 shares.

02Is Rossari Biotech Ltd stock a good investment for long-term?

Rossari Biotech Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹2,835.07 crores, P/E ratio of 18.77, ROE of 11.85%, and ROCE of 15.80%. The dividend yield stands at 0.10%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Rossari Biotech Ltd stock?

The 52-week high price of Rossari Biotech Ltd (ROSSARI) is ₹766, while the 52-week low is ₹375. Currently trading at ₹511.5, the stock is 34.9% away from its 52-week low and 33.2% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Rossari Biotech Ltd stock at the current price?

Whether to buy Rossari Biotech Ltd stock at ₹511.5 depends on multiple factors. The stock is currently trading with a P/E ratio of 18.77 and P/B ratio of 2.10. Today's performance shows a gain of 1.50%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Rossari Biotech Ltd and when is the next dividend?

Rossari Biotech Ltd offers a dividend yield of 0.10%, which means for every ₹100 invested at the current price of ₹511.5, you can expect to receive approximately ₹0.10 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Rossari Biotech Ltd?

Rossari Biotech Ltd's key financial metrics include: P/E Ratio: 18.77, P/B Ratio: 2.10, ROE: 11.85%, ROCE: 15.80%, Dividend Yield: 0.10%, EPS: ₹26.91, Book Value: ₹240.76, and Debt-to-Equity: 32.70. The company's market cap stands at ₹2,835.07 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Rossari Biotech Ltd stock performing today in the market?

Rossari Biotech Ltd stock opened at ₹510 and is currently trading at ₹511.5, showing a gain of ₹7.55 (1.50%). The intraday high is ₹517.9 and low is ₹506.45. The trading volume stands at 50,507 shares, indicating moderate market participation today.

08What is the P/E ratio of Rossari Biotech Ltd and what does it indicate?

Rossari Biotech Ltd has a Price-to-Earnings (P/E) ratio of 18.77, which means investors are willing to pay ₹18.77 for every ₹1 of earnings. With an EPS of ₹26.91, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Rossari Biotech Ltd (ROSSARI) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.